The chart below shows how SIBN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, SIBN sees a +5.85% change in stock price 10 days leading up to the earnings, and a -3.25% change 10 days following the report. On the earnings day itself, the stock moves by -1.59%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Quarterly Revenue Increase: In the third quarter, we delivered world-wide revenue of $40.3 million, reflecting 19% growth.
Adjusted EBITDA Progress: We were close to adjusted EBITDA break even and used only $700,000 in cash in the quarter.
Territory Revenue Increase: Our trailing 12-month revenue per territory increased 21% to $1.8 million.
Physician Growth Increase: We ended the quarter with over 1,200 active physicians, an increase of nearly 150 physicians.
Future Collaboration Excitement: We are excited about the future we can build together.
Negative
Quarterly Net Loss Improvement: S I - B O N E reported a net loss of $6.6 million for the quarter, reflecting a 34% improvement year-over-year, but still indicating ongoing financial challenges.
Operating Expenses Increase: Operating expenses increased by 4% to $39.5 million, which could pressure profitability despite revenue growth.
EBITDA Loss Analysis: The adjusted EBITDA loss was $200,000, indicating that the company is still struggling to reach profitability despite improvements in revenue.
Flat Gross Margin Analysis: The gross margin remained flat at 79%, suggesting that cost management efforts may not be translating into improved margins.
Hurricane Impact on Revenue: The company experienced scheduling impacts and cancellations in certain markets due to Hurricane Idalia, which could affect future revenue growth.
SI-BONE, Inc. (SIBN) Q3 2024 Earnings Call Transcript
SIBN.O
-1.64%